GALT Conference

Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Published September 02, 2025 at 12:00 PM

(NASDAQ:GALT) NORCROSS, Ga., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will participate in the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8-10, 2025 in New York, NY.